WealthTrust-Arizona’s BioMarin Pharmaceuticals BMRN Stock Holding History

WealthTrust-Arizona’s Portfolio BMRN Stock Details BMRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	$44K	Hold	516	–	–	0.03%	165
2018 Q3	$50K	Buy	516 +23	+5%	+$2.3K	0.02%	160
2018 Q2	$46K	Buy	+493	New	+$43.2K	0.02%	161
2017 Q3	–	Sell	-29	Closed	-$3K	–	652
2017 Q2	$3K	Buy	+29	New	+$2.64K	﹤0.01%	523
2013 Q4	–	Sell	-7	Closed	-$1K	–	656
2013 Q3	$1K	Buy	+7	New	+$465	﹤0.01%	600

Other funds holding BMRN

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

WealthTrust-Arizona's BMRN Position: Q4 2018 in Review

WealthTrust-Arizona held its BioMarin Pharmaceuticals (BMRN) position steady in Q4 2018 at 516 shares worth $44K. The position accounts for 0.03% of the portfolio, ranked #165.

WealthTrust-Arizona first reported a position in BMRN in Q3 2013 and has held it in 5 quarters since. The position peaked at $50K in Q3 2018. 473 funds tracked by Wall St. Rank hold BMRN as of Q4 2018.

WealthTrust-Arizona held 516 shares of BioMarin Pharmaceuticals worth $44K as of Q4 2018.
WealthTrust-Arizona left its BioMarin Pharmaceuticals share count unchanged in Q4 2018.
BioMarin Pharmaceuticals made up 0.03% of WealthTrust-Arizona's portfolio in Q4 2018, its #165 holding.
WealthTrust-Arizona first reported a position in BioMarin Pharmaceuticals in Q3 2013 and has held it in 5 quarters since.
WealthTrust-Arizona's BioMarin Pharmaceuticals position peaked at $50K in Q3 2018.
473 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q4 2018.

Based on WealthTrust-Arizona's 13F filing for Q4 2018, filed 7 Feb 2019.